The DEEP project has received research funding from the European Union under the 7th Framework Programme

News | DEEP Project - Part 7

Medical care and transition phase of thalassemia in different countries: the ICET-A experience

Febbraio 5, 2016
|
Comments off
|

During the last Enpr-EMA (European Network of Paediatric Research at the European Medicines Agency) workshop, held in May 2015, adhering networks have been invited to provide a feedback on published guidance documents on the topic of transition from paediatrics to adults clinical care settings within the long […]

Share
Read more →

What is the minimum dose to start the IMPs?

Gennaio 26, 2016
|
Comments off
|

The starting dose for Deferiprone is 75 mg/kg/day, and for Deferasirox 20 mg/kg/day of DFX. Furthermore to avoid a disadvantage for patients who have reached higher doses prior to randomization, the starting dose can equal the previous one but only if it is within […]

Share
Read more →

Prof. Amal El-Beshlawy: Winner of Sultan bin Khalifa International Thalassemia Award 2015

Dicembre 28, 2015
|
Comments off
|

Sheikh Sultan bin Khalifa Al Nahyan Humanitarian and Science Foundation has announced the winners of the second round of the Sultan bin Khalifa International Thalassemia Award (SITA), which was held in Abu Dhabi on 21st October, 2015 with the aim to reward significant contributions in the field of […]

Share
Read more →

DEEP on the National Albanian Television

Ottobre 30, 2015
|
Comments off
|

In the context of 3rd edition of the DEEP Open Meeting “Networking and Innovation for local development” organised in Tirana (May 18th, 2015) in collaboration with the University Hospital Center “Mother Teresa” (UHCT), Donato Bonifazi, DEEP Project Manager and Dr. Manika Kreka, DEEP-2 Principal Investigator have been […]

Share
Read more →